Mycosis fungoides secondary prevention: Difference between revisions

	Cutaneous T cell lymphoma Microchapters
Home
Patient Information
Overview
Classification Mycosis fungoides Sezary syndrome
Pathophysiology

Revision as of 17:21, 26 December 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Revision as of 12:37, 20 August 2015 (view source) Jyostna Chouturi (talk \| contribs) No edit summary ← Older edit	Revision as of 17:21, 26 December 2018 (view source) Anmol Pitliya (talk \| contribs) m (Anmol Pitliya moved page Cutaneous T cell lymphoma secondary prevention to Mycosis fungoides secondary prevention without leaving a redirect) Newer edit →
(No difference)